- Home
- GILD vs SHW Comparison
GILD vs SHW Comparison
Compare GILD & SHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- SHW
- Stock Information
- Founded
- GILD 1987
- SHW 1866
- Country
- GILD United States
- SHW United States
- Employees
- GILD N/A
- SHW N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- SHW RETAIL: Building Materials
- Sector
- GILD Health Care
- SHW Consumer Discretionary
- Exchange
- GILD Nasdaq
- SHW Nasdaq
- Market Cap
- GILD 110.9B
- SHW 98.0B
- IPO Year
- GILD 1992
- SHW N/A
- Fundamental
- Price
- GILD $88.46
- SHW $375.35
- Analyst Decision
- GILD Buy
- SHW Buy
- Analyst Count
- GILD 24
- SHW 21
- Target Price
- GILD $93.91
- SHW $395.29
- AVG Volume (30 Days)
- GILD 7.3M
- SHW 2.7M
- Earning Date
- GILD 11-06-2024
- SHW 10-22-2024
- Dividend Yield
- GILD 3.48%
- SHW 0.76%
- EPS Growth
- GILD N/A
- SHW 7.52
- EPS
- GILD 0.10
- SHW 10.03
- Revenue
- GILD $28,299,000,000.00
- SHW $23,053,500,000.00
- Revenue This Year
- GILD $5.71
- SHW $1.35
- Revenue Next Year
- GILD $0.37
- SHW $4.38
- P/E Ratio
- GILD $911.55
- SHW $37.40
- Revenue Growth
- GILD 3.31
- SHW 0.10
- 52 Week Low
- GILD $62.07
- SHW $269.28
- 52 Week High
- GILD $98.90
- SHW $392.57
- Technical
- Relative Strength Index (RSI)
- GILD 46.13
- SHW 48.57
- Support Level
- GILD $89.01
- SHW $383.33
- Resistance Level
- GILD $98.90
- SHW $391.99
- Average True Range (ATR)
- GILD 2.11
- SHW 7.20
- MACD
- GILD -0.63
- SHW 0.63
- Stochastic Oscillator
- GILD 8.58
- SHW 51.63
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
About SHW Sherwin-Williams Company (The)
Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 5,000 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.